Ovagen
Also known as: Ovagen
Ovagen is a short synthetic bioregulator peptide studied for supporting liver function and protein synthesis. It belongs to the Khavinson family of tissue-specific peptide bioregulators.
Last updated
Mechanism of Action
Ovagen is a short peptide bioregulator from the Khavinson class hypothesized to act as a gene-regulating signaling molecule with tissue tropism for the liver and digestive system. Such peptides are proposed to enter cells and interact with DNA promoter regions to normalize tissue-specific gene expression and protein synthesis. In the liver this is studied as support for hepatocyte function, detoxification capacity, and restoration of normal regenerative activity. The broader bioregulator hypothesis frames these peptides as restoring age- or stress-disrupted cellular homeostasis rather than acting as conventional drugs.
- Half-life
- Short, on the order of minutes to a few hours for short peptides
- Administration Routes
- subcutaneous
- Research Status
- Research Chemical
Reported Benefits
- Studied for support of liver and hepatocyte function
- May aid normalization of protein synthesis
- Investigated for digestive and detoxification support
- Proposed to help restore tissue-specific gene expression
- Explored within longevity bioregulator research
Potential Side Effects
- Injection-site irritation or redness
- Possible transient fatigue
- Limited independent safety data
- Unknown long-term effects in humans
Common Dosing
For research use only and not personal medical advice: bioregulator protocols commonly reference short courses of low-microgram-to-low-milligram amounts, with regimens varying by source. Not approved for human use.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Pregnancy or breastfeeding
- Known hypersensitivity to the peptide
- Active malignancy without clinician oversight
Livagen
Livagen is a short synthetic peptide (Lys-Glu-Asp-Ala) developed in Russian peptide bioregulator research, studied for liver function and chromatin activation. It is positioned within the longevity and anti-aging space.
Vesugen
Vesugen is a short tripeptide bioregulator studied for support of the vascular system and blood-vessel wall integrity. It is part of the Khavinson peptide family aimed at tissue-specific regulation.
Pinealon
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) studied in Russian research as a brain-targeted peptide bioregulator with proposed neuroprotective and cognition-supporting effects. It is part of the Khavinson short-peptide bioregulator family.
N-Acetyl Epitalon Amidate
A modified, more stable form of the tetrapeptide Epitalon studied for telomerase activation and pineal-mediated circadian and longevity effects.
No notable studies catalogued for Ovagen yet.